Literature DB >> 27106629

Bleomycin induced flagellate erythema in a patient with thalamic mixed germ cell tumour: Report of a rare adverse effect.

Ahitagni Biswas1, Pramod Kumar Julka2.   

Abstract

Bleomycin induced flagellate dermatitis is an uncommon and unique adverse effect. With the declining use of bleomycin, this complication is becoming increasingly infrequent in day-to-day clinical practice. We herein describe a case of a 13year old male patient with left thalamic mixed germ cell tumour treated by multimodality approach, who developed flagellate erythema after two cycles of combination chemotherapy with bleomycin, etoposide and cisplatin (BEP). This brief report highlights the importance of awareness and timely identification and management of this dermatological toxicity in patients undergoing bleomycin based combination chemotherapy.
Copyright © 2016 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bleomycin; Dermatitis; Erythema; Flagellate

Mesh:

Substances:

Year:  2016        PMID: 27106629     DOI: 10.1016/j.jnci.2016.04.002

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  2 in total

1.  Flagellate dermatitis in bleomycin chemotherapy: a causality?

Authors:  Niken Indrastuti; Sri Mariyani; Prima Meidiyanti
Journal:  BMJ Case Rep       Date:  2022-07-21

2.  Flagellate Rash: An Unusual Complication of Bleomycin Therapy - A Case Report with Brief Review of Literature.

Authors:  Chaturbhuj Agrawal; Vineet Talwar; Rajeev Saini; Pradeep Babu
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.